Svoboda | Graniru | BBC Russia | Golosameriki | Facebook

Evaluation of fidaxomicin use in patients with a macrolide allergy/intolerance

J Antimicrob Chemother. 2023 Apr 3;78(4):1127-1128. doi: 10.1093/jac/dkad036.

Authors

Wesley D Kufel^{1

2

3}, Allison M Hitchcock³, Alexis N Delbalso¹, Kristopher M Paolino^{2

3}

Affiliations

¹ Department of Pharmacy Practice, Binghamton University School of Pharmacy and Pharmaceutical Sciences, PO Box 6000, Binghamton, NY 13902-6000, USA.
² Department of Medicine Division of Infectious Diseases, State University of New York Upstate Medical University, Syracuse, NY, USA.
³ Department of Pharmacy, State University of New York Upstate University Hospital, 750 East Adams Street, Syracuse, NY 13210, USA.

PMID: 36790902
DOI: 10.1093/jac/dkad036

No abstract available

Publication types

Letter

MeSH terms

Aminoglycosides
Anti-Bacterial Agents / adverse effects
Clostridium Infections* / drug therapy
Fidaxomicin / therapeutic use
Humans
Hypersensitivity* / drug therapy
Macrolides / adverse effects
Vancomycin

Substances

Fidaxomicin
Macrolides
Anti-Bacterial Agents
Vancomycin
Aminoglycosides